NCT07262619
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07262619
Title EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Eikon Therapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NZL | AUS

Facility Status City State Zip Country Details
Morristown Medical Center NOT_YET_RECRUITING Morristown New Jersey 07960 United States Details
Memorial Sloan Kettering Cancer Center (MSKCC) NOT_YET_RECRUITING New York New York 10022 United States Details
University of Texas MD Anderson Cancer Center NOT_YET_RECRUITING Houston Texas 77030 United States Details
GenesisCare North Shore (Oncology) NOT_YET_RECRUITING Saint Leonards New South Wales Australia Details
Calvary Mater Newcastle Hospital RECRUITING Waratah New South Wales Australia Details
Grampians Health RECRUITING Ballarat Victoria Australia Details
Chris O'Brien Lifehouse (Sydney Cancer Centre) NOT_YET_RECRUITING Camperdown Victoria Australia Details
Oncology Clinics Victoria (OCV) - Cabrini Brighton Hospital NOT_YET_RECRUITING Frankston Victoria 3199 Australia Details
Peninsula and Southeast Oncology (PASO) Medical RECRUITING Frankston Victoria Australia Details
Health New Zealand NOT_YET_RECRUITING Wellington New Zealand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field